Facebook
X
LinkedIn
ForwardThis course will provide an overview of different types of acquired thrombocytopenia. It will help clinicians gain familiarity with the pathogenesis of acquired thrombocytopenia and be able to establish a differential diagnosis. Thrombocytopenia is among the most common reason for consultation with a hematologist for both in-patients and out-patients. There are different disorders which can cause a low platelet count and put a patient at risk for bleeding. The course will help clinicians to understand the differences among the different underlying disorders and how to appropriately manage impacted patients.
This program is sponsored by an unrestricted educational grant by: Dova Pharmaceutical
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis (ISTH). The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1 hours of participation for continuing education for allied health professionals.
This activity is intended for physicians involved in the diagnosis and management of patients who have a low platelet count.
- Recognize the clinical symptoms characteristic of drug-induced immune thrombocytopenia (DITP).
- List the 5 drugs most frequently implicated in DITP.
- Distinguish DITP from other immune thrombocytopenias, e.g., ITP, PP, IPR.
- List the 5 drugs most frequently implicated in DITP.
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
| Name | Company | Role |
|---|---|---|
| Tamam Bakchoul, MD | Aspen GMbH Germany, CSL-Behring and Hämostase Update | Speaker |
| Brian Curtis | Ionis Pharmaceuticals | Advisory Board Member |
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.